Breast Cancer Market - Trends Forecast Till 2028

Market Overview

The global breast cancer market is anticipated to reach USD 31.5 billion by 2020 growing at a CAGR of 9.6% during the forecasting period, 2020-2028. Breast cancer is the result of uncontrolled cell division of breast cells, the most common cells of breast lobule and ducts. It may also affect fatty or connective tissues within the breasts. Breast cancer is the second most common type of cancer worldwide, affecting nearly 2 million women. Factors such as the rising geriatric population along with cancer incidences, rising focuses on research & development in the medical field for cancers is another factor driving the market for the global breast cancer market

Key Findings

The global breast cancer market is segmented into drug class, surgery, therapies, end-users, and geography.

Drugs Class segment is segmented into Chemotherapy Drugs, Hormone Therapy, Targeted Therapy. 

The surgery segment is segmented into Lumpectomy, Mastectomy, and Reconstructive Surgery. The reconstructive surgery segment is segmented into Tissue Flap Procedures, Implants. Tissue Flap Procedure is further segmented into Latissimus Dorsi Flap, Transverse Rectus Abdominis Muscle (TRAM) Flap, Deep Inferior Epigastric Artery Perforator (Diep) Flap, and Gluteal Free Flap.

 Phase segment is segmented into PHASE I, PHASE II, PHASE III, and PHASE IV

The therapies segment is segmented into Radiation Therapy, Targeted Therapy, Chemotherapy, Hormonal Therapy, Others. Radiation Therapy has been segmented into External-Beam Radiation Therapy, Intra-Operative Radiation Therapy, Brachytherapy, Proton Therapy, Intensity-Modulated Radiation Therapy, Partial Breast Irradiation, Neoadjuvant Radiation Therapy, and Adjuvant Radiation Therapy. Radiation Therapy has been segmented on the basis of the schedule into After a Mastectomy, After a Lumpectomy. Targeted Therapy has been further segmented into Trastuzumab, Pertuzumab (PERJETA), Neratinib (NERLYNX). Hormonal Therapy has been further segmented into Aromatase Inhibitors (AIS), Tamoxifen, and Ovarian Suppression. Ovarian Suppression has been further segmented on the basis of methods into Gonadotropin or Luteinizing Hormone-Releasing and Ovaries Removal.

End Users segment is segmented into Oncology Centers, Hospitals and Specialty Centers, Academic Research Institutes and Laboratories and Others

Geographically, the global breast cancer market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions

Regional Analysis

North America region is the largest contributor to the breast cancer market in the forecast period 2020-2028.

Competitive Landscape

Key players in the global breast cancer market are Novartis AG, Pfizer Inc., Merck & Co Inc., Janssen Global Services Llc, Celgene Corporation, Astellas Pharma Inc., Genzyme Corporation, F. Hoffman-LA Roche Pvt. Ltd, AstraZeneca, Astellas Pharma, Abbvie, Inc., Genentech, Inc., Macrogenics Inc., Celldex Therapeutics, Onyx Pharmaceuticals, Inc., Bionumerik Pharmaceuticals Inc, Eagle Pharma, Seattle Genetics, Smith & Nephew, Inc., Baxter, Bayer, Tesaro, Sanofi, Incyte Corporation, Immunomed among others.

Recent Developments

The companies have come up with various promotional activities in from of launch, investment, acquisition, and other, for instance:

• In 2017, Cynvenio Biosystems, Inc has launched a second-generation PD-L1 expression test. This new blood test helps in offering improved analytic performance as compared to the first-generation PD-L1 test and has high sensitivity.
• In 2017, Cynvenio Biosystems Inc has released a liquid biopsy monitoring service named ClearID Total Insight Breast Cancer which is used for patients helps in treating cancer-related problems

Reasons to Acquire

• Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
• Gain authentic and granular data access for the breast cancer market so as to understand the trends and the factors involved in changing market situations
• Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
• In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope